Shuji Noguchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shuji Noguchi has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Masataka Ito
Faculty of Pharmaceutical Sciences, Toho University
6 shared publications - Hironori Suzuki
Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan
4 shared publications - Yasunori Iwao
Department of Physical Pharmaceutics, School of Pharmaceutical Sciences, Wakayama Medical University, 25-1 Shichiban-cho, Wakayama 640-8156, Japan
3 shared publications - Keisuke Ueda
Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan
2 shared publications - Kenjirou Higashi
Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba 260-8675, Japan
2 shared publications - Kunikazu Moribe
Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan
2 shared publications
Latest Publications
- 18 July 2026
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 38 (15) , 7887-7897
Electronic-State Fingerprints of Protonation in Crystalline and Amorphous Molecular Solids
Resolving protonation-dependent electronic states in molecular solids remains a fundamental challenge, particularly in disordered materials where conventional structural methods fail to provide molecular-level insight. Here, we establish sulfur K-edge X-ray absorption near-edge spectroscopy (XANES) as an atom-specific probe that captures electronic-state fingerprints of protonation and intermolecular interactions in sulfonyl-containing molecular solids. Using glyclopyramide as a representative sulfonylurea compound, crystalline salts, cocrystals, and coamorphous phases were systematically investigated to elucidate how proton transfer modulates local electronic structure. Distinct S K-edge spectral features are highly sensitive to electronic changes in the sulfonylurea moiety, enabling clear discrimination between molecular and ionic states. Notably, these electronic-state fingerprints persist in coamorphous phases, demonstrating that protonation-dependent electronic structures can be resolved even in the absence of long-range order. Correlation of the spectral signatures with supramolecular synthons further reveals a clear relationship between local electronic structure and supramolecular organization across crystalline and amorphous phases. In contrast, Cl K-edge spectra primarily report local chemical environments, highlighting the unique electronic sensitivity of sulfur K-edge analysis. These findings establish electronic-state fingerprints as a robust descriptor of proton-transfer-driven interactions, providing a general framework for understanding and designing crystalline and amorphous molecular materials.s electronic changes in the sulfonylurea moiety, enabling clear discrimination between molecular and ionic states. Notably, these electronic-state fingerprints persist in coamorphous phases, demonstrating that protonation-dependent electronic structures can be resolved even in the absence of long-range order. Correlation of the spectral signatures with supramolecular synthons further reveals a clear relationship between local electronic structure and supramolecular organization across crystalline and amorphous phases. In contrast, Cl K-edge spectra primarily report local chemical environments, highlighting the unique electronic sensitivity of sulfur K-edge analysis. These findings establish electronic-state fingerprints as a robust descriptor of proton-transfer-driven interactions, providing a general framework for understanding and designing crystalline and amorphous molecular materials.
- 18 July 2026
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 38 (15) , 7887-7897
Electronic-State Fingerprints of Protonation in Crystalline and Amorphous Molecular Solids
Resolving protonation-dependent electronic states in molecular solids remains a fundamental challenge, particularly in disordered materials where conventional structural methods fail to provide molecular-level insight. Here, we establish sulfur K-edge X-ray absorption near-edge spectroscopy (XANES) as an atom-specific probe that captures electronic-state fingerprints of protonation and intermolecular interactions in sulfonyl-containing molecular solids. Using glyclopyramide as a representative sulfonylurea compound, crystalline salts, cocrystals, and coamorphous phases were systematically investigated to elucidate how proton transfer modulates local electronic structure. Distinct S K-edge spectral features are highly sensitive to electronic changes in the sulfonylurea moiety, enabling clear discrimination between molecular and ionic states. Notably, these electronic-state fingerprints persist in coamorphous phases, demonstrating that protonation-dependent electronic structures can be resolved even in the absence of long-range order. Correlation of the spectral signatures with supramolecular synthons further reveals a clear relationship between local electronic structure and supramolecular organization across crystalline and amorphous phases. In contrast, Cl K-edge spectra primarily report local chemical environments, highlighting the unique electronic sensitivity of sulfur K-edge analysis. These findings establish electronic-state fingerprints as a robust descriptor of proton-transfer-driven interactions, providing a general framework for understanding and designing crystalline and amorphous molecular materials.s electronic changes in the sulfonylurea moiety, enabling clear discrimination between molecular and ionic states. Notably, these electronic-state fingerprints persist in coamorphous phases, demonstrating that protonation-dependent electronic structures can be resolved even in the absence of long-range order. Correlation of the spectral signatures with supramolecular synthons further reveals a clear relationship between local electronic structure and supramolecular organization across crystalline and amorphous phases. In contrast, Cl K-edge spectra primarily report local chemical environments, highlighting the unique electronic sensitivity of sulfur K-edge analysis. These findings establish electronic-state fingerprints as a robust descriptor of proton-transfer-driven interactions, providing a general framework for understanding and designing crystalline and amorphous molecular materials.
- 23 June 2025
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 22 (7) , 4091-4100
Thermodynamic Perspectives on the Impact of a Second Drug on Amorphous Drug Solubility
Drug amorphous solubility can be changed in the presence of other compounds, making it essential to elucidate the underlying mechanisms for designing supersaturated formulations. In this study, we experimentally determined how a second drug affects the amorphous solubility of ritonavir (RTV) and analyzed these effects from a thermodynamic perspective. Lopinavir (LPV), cilnidipine (CND), and probucol (PBC) were used as second drugs. The coexistence of each second drug in an aqueous solution reduced the amorphous solubility of RTV. In the presence of LPV and CND, the experimentally determined RTV amorphous solubility was close to the value predicted under the assumption of ideal mixing of RTV and second drugs. In contrast, in the presence of PBC, the experimentally determined RTV amorphous solubility exceeded the predicted value. Dynamic vapor sorption (DVS) measurements revealed that the RTV/LPV coamorphous absorbed water similarly to amorphous RTV. Conversely, water absorption in the RTV/CND and RTV/PBC coamorphous decreased compared with amorphous RTV. Using the experimentally determined amorphous solubilities and water absorption data, the interaction parameters between RTV and each second drug within the water-saturated drug-rich phase were calculated. The absolute value of the interaction parameter in the RTV/LPV system is relatively small, suggesting that incorporating LPV into the RTV-rich phase had minimal impact on water absorption and drug-drug interaction strength in the RTV-rich phase, resulting in experimentally determined solubility values that align closely with those predicted by ideal mixing of RTV and LPV. Meanwhile, the interaction parameters of the RTV/CND and RTV/PBC systems were negative, indicating relatively strong drug-drug interactions that can further reduce RTV amorphous solubility. However, for these two systems, the mixing of second drugs also decreased the water content in the RTV-rich phase, which would mitigate the extent of the solubility reduction. In the RTV/CND system, the strong drug-drug interaction and reduced water content largely offset each other. This results in an experimentally determined RTV amorphous solubility similar to the value predicted by the ideal mixing of RTV and CND. In contrast, in the RTV/PBC system, the water content of the RTV-rich phase was more substantially decreased, leading to a higher experimentally determined value of RTV amorphous solubility than that predicted by ideal mixing of RTV and PBC. Overall, this study elucidates the impact of a second drug on the amorphous solubility of a primary drug and provides valuable insights for the design of supersaturated formulations containing multiple drugs.
- 23 June 2025
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 22 (7) , 4091-4100
Thermodynamic Perspectives on the Impact of a Second Drug on Amorphous Drug Solubility
Drug amorphous solubility can be changed in the presence of other compounds, making it essential to elucidate the underlying mechanisms for designing supersaturated formulations. In this study, we experimentally determined how a second drug affects the amorphous solubility of ritonavir (RTV) and analyzed these effects from a thermodynamic perspective. Lopinavir (LPV), cilnidipine (CND), and probucol (PBC) were used as second drugs. The coexistence of each second drug in an aqueous solution reduced the amorphous solubility of RTV. In the presence of LPV and CND, the experimentally determined RTV amorphous solubility was close to the value predicted under the assumption of ideal mixing of RTV and second drugs. In contrast, in the presence of PBC, the experimentally determined RTV amorphous solubility exceeded the predicted value. Dynamic vapor sorption (DVS) measurements revealed that the RTV/LPV coamorphous absorbed water similarly to amorphous RTV. Conversely, water absorption in the RTV/CND and RTV/PBC coamorphous decreased compared with amorphous RTV. Using the experimentally determined amorphous solubilities and water absorption data, the interaction parameters between RTV and each second drug within the water-saturated drug-rich phase were calculated. The absolute value of the interaction parameter in the RTV/LPV system is relatively small, suggesting that incorporating LPV into the RTV-rich phase had minimal impact on water absorption and drug-drug interaction strength in the RTV-rich phase, resulting in experimentally determined solubility values that align closely with those predicted by ideal mixing of RTV and LPV. Meanwhile, the interaction parameters of the RTV/CND and RTV/PBC systems were negative, indicating relatively strong drug-drug interactions that can further reduce RTV amorphous solubility. However, for these two systems, the mixing of second drugs also decreased the water content in the RTV-rich phase, which would mitigate the extent of the solubility reduction. In the RTV/CND system, the strong drug-drug interaction and reduced water content largely offset each other. This results in an experimentally determined RTV amorphous solubility similar to the value predicted by the ideal mixing of RTV and CND. In contrast, in the RTV/PBC system, the water content of the RTV-rich phase was more substantially decreased, leading to a higher experimentally determined value of RTV amorphous solubility than that predicted by ideal mixing of RTV and PBC. Overall, this study elucidates the impact of a second drug on the amorphous solubility of a primary drug and provides valuable insights for the design of supersaturated formulations containing multiple drugs.
- 18 August 2023
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 23 (9) , 6298-6307
Cocrystal or Salt Crystallization for Active Pharmaceutical Ingredients By Using Deep Eutectic Solvents
- 18 August 2023
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 23 (9) , 6298-6307
Cocrystal or Salt Crystallization for Active Pharmaceutical Ingredients By Using Deep Eutectic Solvents
- 15 February 2023
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 635, 122723
Comparison of the physical properties of disodium etidronate amorphous forms prepared by different manufacturing methods
- 15 February 2023
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 635, 122723
Comparison of the physical properties of disodium etidronate amorphous forms prepared by different manufacturing methods
- 23 December 2022
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 20 (2) , 1213-1221
Analysis of Cimetidine Crystal Polymorphs by X-ray Absorption Near-Edge Spectroscopy
Sulfur K-edge X-ray absorption near-edge spectroscopy (XANES) measurements were performed to characterize the crystal polymorphs of the active pharmaceutical ingredients (APIs) containing sulfur atoms. Cimetidine (CIM) was used as a model API. Each crystal form of CIM has its own XANES spectrum, so we can discriminate the crystal form by its spectrum. The analysis of the crystal structure of CIM revealed that the difference in the shape of XANES spectra was ascribable to the difference in the C-S-C bond angle of CIM molecules and the intermolecular hydrogen bonds, such as C-H···S and N-H···S, and S-S interaction. It was found that the peak shape of the XANES spectrum is gentle when the C-S-C bond angle is large, while the peak shape can be steep when the C-S-C bond angle is small. Furthermore, it was found that the peak energy values varied depending on the hydrogen bonds and S-S interaction. By linear combination fitting using XANES spectra, it was possible to quantify the ratio of CIM form A crystal in mixed powders of form A and monohydrate crystals. These results indicate that XANES measurements can be a useful technique to evaluate the crystal polymorphism of APIs containing S atom in pharmaceutical formulation.
- 23 December 2022
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 20 (2) , 1213-1221
Analysis of Cimetidine Crystal Polymorphs by X-ray Absorption Near-Edge Spectroscopy
Sulfur K-edge X-ray absorption near-edge spectroscopy (XANES) measurements were performed to characterize the crystal polymorphs of the active pharmaceutical ingredients (APIs) containing sulfur atoms. Cimetidine (CIM) was used as a model API. Each crystal form of CIM has its own XANES spectrum, so we can discriminate the crystal form by its spectrum. The analysis of the crystal structure of CIM revealed that the difference in the shape of XANES spectra was ascribable to the difference in the C-S-C bond angle of CIM molecules and the intermolecular hydrogen bonds, such as C-H···S and N-H···S, and S-S interaction. It was found that the peak shape of the XANES spectrum is gentle when the C-S-C bond angle is large, while the peak shape can be steep when the C-S-C bond angle is small. Furthermore, it was found that the peak energy values varied depending on the hydrogen bonds and S-S interaction. By linear combination fitting using XANES spectra, it was possible to quantify the ratio of CIM form A crystal in mixed powders of form A and monohydrate crystals. These results indicate that XANES measurements can be a useful technique to evaluate the crystal polymorphism of APIs containing S atom in pharmaceutical formulation.
- 1 November 2015
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 495 (1) , 204-217
Effect of surfactants or a water soluble polymer on the crystal transition of clarithromycin during a wet granulation process
- 1 November 2015
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 495 (1) , 204-217
Effect of surfactants or a water soluble polymer on the crystal transition of clarithromycin during a wet granulation process
- 1 April 2015
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 483 (1-2) , 49-56
A newly developed lubricant, chitosan laurate, in the manufacture of acetaminophen tablets
- 1 April 2015
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 483 (1-2) , 49-56
A newly developed lubricant, chitosan laurate, in the manufacture of acetaminophen tablets
- 1 May 2013
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 448 (1) , 1-8
An easy-to-use approach for determining the disintegration ability of disintegrants by analysis of available surface area
- 1 May 2013
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 448 (1) , 1-8
An easy-to-use approach for determining the disintegration ability of disintegrants by analysis of available surface area